Approval for modifications to the delivery system that composes the mynxgrip vascular closure device. the device, as modified, will be marketed under the trade name mynx ace vascular closure device ("mynx ace") and is indicated for use to seal femoral arterialaccess sites while reducing times to hemostasis and ambulation in patients who have undergone diagnostic or interventional endovascular procedures utilizing a 5f, 6f or 7f procedural sheath.